β4-integrin-mediated cytotoxic activity of AexU in human prostate cancer PC3 cells

Oncology Letters

Volumn 6, Issue 5, 2013, Pages 1482-1486

  Kumano, Masafumi ^a   Miyake, Hideaki ^a   Abolghait, Said K ^b   Behnsawy, Hosny M ^a,c   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SUEZ CANAL UNIVERSITY   (Egypt)

^c Assiut University Faculty of Medicine   (Egypt)

Author keywords

4 integrin; AexU; Antitumor effect; Prostate cancer

Indexed keywords

BACTERIAL PROTEIN; BETA4 INTEGRIN; CASPASE 3; CISPLATIN; DOCETAXEL; PROTEIN AEXU; PROTEIN BAX; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CHEMOSENSITIZATION; CONTROLLED STUDY; CYTOTOXICITY; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 84884487446     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1542     Document Type: Article

References (23)

1. Ghosh P: Process of protein transport by the type III secretion system. Microbiol Mol Biol Rev 68: 771-795, 2004.
2. Braun M, Stuber K, Schlatter Y, Wahli T, Kuhnert P and FreyJ: Characterization of an ADP-ribosyltransferase toxin (AexT) from Aeromonas salmonicida subsp. salmonicida. J Bacteriol184: 1851-1858, 2002.
3. Sha J, Wang SF, Suarez G, et al: Further characterization of a type III secretion system (T3SS) and of a new effector protein from a clinical isolate of Aeromonas hydrophila-part I. Microb Pathog 43: 127-146, 2007.
4. Sierra JC, Suarez G, Sha J, et al: Biological characterization of a new type III secretion system effector from a clinical isolate of Aeromonas hydrophila-part II. Microb Pathog 43: 147-160, 2007.
5. Khajanchi BK, Sha J, Kozlova EV, et al: N-acylhomoserine lactones involved in quorum sensing control the typeVI secretion system, biofilm formation, protease production, and in vivo virulence in a clinical isolate of Aeromonas hydrophila. Microbiology 155: 3518-3531, 2009
6. LaFlamme SE, Nieves B, Colello D and Reverte CG: Integrins as regulators of the mitotic machinery. Curr Opin Cell Biol 20: 576-582, 2008.
7. Gilcrease MZ: Integrin signaling in epithelial cells. Cancer Lett247: 1-25, 2007.
8. Guo W and Giancotti FG: Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5: 816-826, 2004.
9. Vicente-Manzanares M, Choi CK and Horwitz AR: Integrins in cell migration-the actin connection. J Cell Sci 122: 199-206, 2009
10. Abolghait SK, Iida T, Kodama T, Cantarelli VV, Akeda Y and HondaT: Recombinant AexU effector protein of Aeromonasveronii bv. sobria disrupts the actin cytoskeleton by downregulation of Rac1 and induces direct cytotoxicity to β4-integrin expressing cell lines. Microb Pathog 51: 454-465, 2011
11. Choi YP, Kim BG, Gao MQ, Kang S and Cho NH: Targeting ILK and β4 integrin abrogates the invasive potential of ovarian cancer. Biochem Biophys Res Commun 427: 642-648, 2012.
12. Gerson KD, Shearstone JR, Maddula VS, Seligmann BE and Mercurio AM: Integrin β4 regulates SPARC protein to promote invasion. J Biol Chem 287: 9835-9844, 2012.
13. Drake JM, Barnes JM, Madsen JM, Domann FE, Stipp CS and Henry MD: ZEB1 coordinately regulates laminin-332 and β4 integrin expression altering the invasive phenotype of prostate cancer cells. J Biol Chem 285: 33940-33948, 2010.
14. Bonaccorsi L, Carloni V, Muratori M, et al: Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype. Endocrinology 141: 3172-3182, 2000.
15. Davis TL, Cress AE, Dalkin BL and Nagle RB: Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma. Prostate 46: 240-248, 2001.
16. Terakawa T, Miyake H, Furukawa J, Ettinger SL, Gleave ME and Fujisawa M: Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells. Br J Cancer 101: 1731-1739, 2009.
17. Kususda Y, Miyake H, Gleave ME and Fujisawa M: Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model. Br JCancer 106: 1945-1952, 2012
18. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
19. Bluemn EG and Nelson PS: The androgen/androgen receptor axis in prostate cancer. Curr Opin Oncol 24: 251-257, 2012.
20. Haddad H and Garcia JA: Novel agents for the management of castration-resistant prostate cancer. Curr Opin Urol 22: 175-182, 2012
21. Kurita A, Gotoh H, Eguchi M, et al: Intracellular expression of the Salmonella plasmid virulence protein, SpvB, causes apoptotic cell death in eukaryotic cells. Microb Pathog 35: 43-48, 2003.
22. Bhattacharjee RN, Park KS, Kumagai Y, et al: VP1686, a Vibrio typeIII secretion protein, induces toll-like receptor-independent apoptosis in macrophage through NF-kappaB inhibition. J Biol Chem 281: 36897-36904, 2006.
23. Molero C, Rodríguez-Escudero I, Alemán A, Rotger R, MolinaM and Cid VJ: Addressing the effects of Salmonella internalization in host cell signaling on a reverse-phase protein array. Proteomics9: 3652-3665, 2009.